Selective destruction of human leukemic cells by alkyl-lysophospholipids.
D001853:Bone Marrow / Q000187:drug effects; D002462:Cell Membrane / Q000187:drug effects; D002470:Cell Survival / Q000187:drug effects; D006801:Humans; D066298:In Vitro Techniques; D007938:Leukemia / Q000188:drug therapy*; D007945:Leukemia, Lymphoid / Q000188:drug therapy / Q000378:metabolism; D007951:Leukemia, Myeloid / Q000188:drug therapy / Q000378:metabolism; D008244:Lysophosphatidylcholines / Q000378:metabolism / Q000494:pharmacology; D010743:Phospholipids / Q000378:metabolism / Q000494:pharmacology*; D013329:Structure-Activity Relationship
D008244:Lysophosphatidylcholines; D010743:Phospholipids